Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA

Cancer Research

Volumn 57, Issue 7, 1997, Pages 1250-1254

  Costello, Joseph F ^a,f   Plass, Christoph ^c   Arap, Wadih ^a,d   Chapman, Verne M ^c   Held, William A ^c   Berger, Mitchel S ^e   Su Huang, H J ^a,b   Cavenee, Webster K ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f LUDWIG INSTITUTE FOR CANCER RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CHROMOSOME MAP; DNA DETERMINATION; EXTRACHROMOSOMAL INHERITANCE; GENE AMPLIFICATION; GLIOMA; HEMATOPOIETIC CELL; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR GENE; SIGNAL TRANSDUCTION; TUMOR GROWTH;

BASE SEQUENCE; BLOTTING, SOUTHERN; BLOTTING, WESTERN; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 7; CLONING, MOLECULAR; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASES; DNA; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE AMPLIFICATION; GLIOMA; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN-SERINE-THREONINE KINASES;

EID: 0030982897     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Schwab, M., and Amler, L. C. Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer. Genes Chromosomes & Cancer, 1: 181-193, 1990.
2. Hatada, I., Hayashizaki, Y., Hirotsune, S., Komatsubara, H., and Mukai, T. A genomic scanning method for higher organisms using restriction sites as landmarks. Proc. Natl. Acad. Sci. USA, 88: 9523-9527, 1991.
3. Lindsay, S., and Bird, A. P. Use of restriction enzymes to detect potential gene sequences in mammalian DMA. Nature (Lond.), 327: 336-338, 1987.
4. Larsen, F., Gundersen, G., Lopez, R., and Prydz, H. CpG islands as gene markers in the human genome. Genomics, 13: 1095-1107, 1992.
5. Yoshikawa, H., Delamonte, S., Nagai, H., Wands, J. R., Matsubara, K., and Fujiyama, A. Chromosomal assignment of human genomic NotI restriction fragments in a two-dimensional electrophoresis profile. Genomics, 31: 28-35, 1996.
6. Hirotsune, S., Hatada, I., Komatsubara, H., Nagai, H., Kuma, K., Kobayakawa, K., Kawara, T., Nakagawara, A., Fujii, K., Mukai, T., and Hayashizaki, Y. New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning. Cancer Res., 52: 3642-3647, 1992.
7. Nagai, H., Tsumura, H., Ponglikitmongkol, M., Kim, Y. S., and Matsubara, K. Genomic aberrations in human hepatoblastomas detected by two-dimensional gel analysis. Cancer Res., 55: 4549-4551 1995.
8. Ohsumi, T., Okazaki, Y., Okuizumi, H., Shibata, K., Hanami, T., Mizuno, Y., Takahara, T., Sasaki, N., Ueda, M., Muramatsu, M., Kerns, K. A., Chapman, V. M., Held, W. A., and Hayashizaki, Y. Loss of heterozygosity in chromosomes 1, 5, 7, and 13 in mouse hepatoma detected by systematic genome-wide scanning using RLGS genetic map. Biochem. Biophys. Res. Commun., 272: 632-639, 1995.
9. Miwa, W., Yashima, K., Sekine, T., and Sekiya, T. Demethylation of a repetitive DNA sequence in human cancers. Electrophoresis, 16: 227-232, 1995.
10. Johnson, E. W., Iyer, L. M., Rich, S. S., Orr, H. T., Gilnagel, A., Kurth, J., Zabranski, J. M., Marchuk, D. A., Weissenbach, J., Clericuzio, C. L., Davis, L. E., Hart, B. L., Gusella, J. F., Kosofsky, B. E., Louis, D. N., Morrison, L. A., Green, E. D., and Weber, J. L. Refined localization of the cerebral cavernous malformation gene (CCMI) to a 4-cM interval of chromosome 7q contained in a well-defined YAC contig. Genome Res., 5: 368-380, 1995.
11. Collins, V. P. Gene amplification in human gliomas, GLIA, 15: 289-296, 1995.
12. Hayashizaki, Y., Hirotsune, S., Hatada, I., Tamatsukuri, S., Miyamoto, C., Furuichi, Y., and Mukai, T. A new method for constructing NotI linking and boundary libraries using a restriction trapper Genomics, 14: 733-739, 1992.
13. Arap, W., Nishikawa, R., Furnari, F. B., Cavenee, W. K., and Huang, H. J. Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Res., 55: 1351-1354, 1995.
14. Kuick, R. M., Asakawa, J., Neel, J. V., Kodaira, M., Satoh, C., Thoraval, D., Gonzalez, I. L., and Hanash, S. M. Studies of the inheritance of human ribosomal DNA variants detected in two-dimensional separations of genomic restriction fragments. Genetics, 144: 307-316, 1996.
15. Meyerson, M., Enders, G. H., Wu, C. L., Su, L. K., Gorka, C., Nelson, C., Harlow, E., and Tsai, L. H. A family of human cdc2-related protein kinases. EMBO J., 11: 2909-2917, 1992.
16. Lewin, B. The organization of interrupted genes. In: Genes III, pp. 384-396. New York: John Wiley & Sons, 1987.
17. Gardiner-Garden, M., and Frommer, M. CpG islands in vertebrate genomes. J. Mol. Biol., 196: 261-282, 1987.
18. Kip1, to regions involved in human cancer. Cancer Res., 55: 1199-1205, 1995.
19. Corvi, R., Savelyeva, L., Breit, S., Wenzel, A., Handgretinger, R., Barak, J., Oren, M., Amler, L., and Schwab, M. Nonsyntenic amplification of MDM2 and MYCN in human neuroblastoma. Oncogene, 10: 1081-1086, 1995.
20. Meyers, M. B., Spengler, B. A., Chang, T. D., Melera, P. W., and Biedler, J. L. Gene amplification-associated cytogenetic aberrations and protein changes in vincristine-resistant Chinese hamster, mouse, and human cells. J. Cell Biol., 100: 588-597, 1985.
21. Plass, C., Kawai, J., Kalcheva, I., Davis, L., Watanabe, S., Hayashizaki, Y., and Chapman, V. Comparative analysis of mouse NotI linking clones with mouse and human genomic sequences and transcripts. DNA Res., 2: 27-35, 1995.
22. Plass, C., Shibata, H., Kalcheva, I., Mullins, L., Kotelevtseva, N., Mullins, J., Kato, R., Sasaki, H., Hirotsune, S., Okazaki, Y., Held, W. A., Hayashizaki, Y., and Chapman, V. Identification of grf 1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat. Genet., 14: 106-109, 1996.
23. Hayashizaki, Y., Shibata, H., Hirotsune, S., Sugino, H., Okazaki, Y., Sasaki, N., Hirose, K., Imoto, H., Okuizumi, H., Muramatsu, M., Komatsubara, H., Shirooishi, T., Moriwaki, K., Katsuki, M., Hatano, N., Sasaki, T., Veda, T., Mise, N., Takagi, N., Plass, C., and Chapman, V. M. Identification of an imprinted U2af binding protein related sequence on mouse chromosome 11 using the RLGS method. Nat. Genet., 6: 33-40, 1994.
24. Kawai, J., Hirose, K., Fushiki, S., Hirotsune, S., Ozawa, N., Hara, A., Hayashizaki, Y., and Watanabe, S. Comparison of DNA methylation patterns among mouse cell lines by restriction landmark genomic scanning. Mol. Cell. Biol., 14: 7421-7427, 1994.
25. Imoto, H., Hirotsune, S., Muramatsu, M., Okuda, K., Sugimoto, O., Chapman, V. M., and Hayashizaki, Y. Direct determination of NotI cleavage sites in the genomic DNA of adult mouse kidney and human trophoblast using whole-range restriction landmark genomic scanning. DNA Res., 1: 39-43, 1994.
26. Antequera, F., and Bird, A. Number of CpG islands and genes in human and mouse, Proc. Natl. Acad. Sci. USA, 90: 1995-1999, 1993.
27. Schröck, E., Thiel, G., Lozanova, T., du Manoir, S., Meffert, M. C., Jauch, A., Speicher, M. R., Nurnberg, P., Vogel, S., Janisch, W., Donis-Keller, H., Ried, T., Witkowski, R. and Cremer, T. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am. J. Pathol., 144: 1203-1218, 1994.
28. Guan, X. Y., Xu, J., Anzick, S. L., Zhang, H., Trent, J. M., and Meltzer, P. S. Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer. Cancer Res., 56: 3446-3450, 1996.
29. Kato, J., Matsushime, H., Hiebert, S. W., Ewen, M. E., and Sherr, C. J. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes & Dev., 7: 331-342, 1993.
30. INK4 or retinoblastoma protein (pRb) or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res., 55: 4833-4836, 1995.